AMPH Amphastar Pharmaceuticals, Inc. - Common Stock

25.26USD-0.67%Mkt Cap: 1.08B $P/E: 15.05

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. I…

Key Statistics

Company
Market Cap1.08B USD
Enterprise Value1.48B USD
Revenue (TTM)730.02M USD
Gross Profit356.06M USD
Net Income (TTM)98.09M USD
Revenue/Share16.10 USD
Last Price25.26 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees2.0K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)15.05
P/E (Forward)7.99
PEG—
EV/EBITDA7.61
EV/Revenue2.03
P/S1.48
P/B1.41
EPS (TTM)1.69
EPS (Forward)3.18
52W Range
16.6567% of range29.52
52W High29.52 USD
52W Low16.65 USD
Profitability
Gross Margin49.46%
Oper. Margin21.60%
EBITDA Margin26.65%
Profit Margin13.63%
ROE12.44%
ROA6.02%
Growth
Revenue Growth5.40%
Earnings Growth4.70%
Cash Flow & Leverage
Operating CF156.12M USD
CapEx (TTM)37.13M USD
FCF Margin31.52%
FCF Yield21.27%
Net Debt398.20M USD
Net Debt/EBITDA2.05
Balance Sheet
Debt/Equity0.83
Current Ratio2.40
Quick Ratio1.66
Book Value/Sh18.06 USD
Cash/Share6.82 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)22.50 USD
Upside (mean)-10.9%
Target Range20.00 USD – 30.00 USD
20.00-10.9% to mean30.00
# Analysts6
Ownership
Shares Out.42.54M
Float31.29M
Insiders30.81%
Institutions68.68%
Short Interest
Short Ratio12.5d
Short % Float25.59%
Short % Out.11.74%
Shares Short4.99M
Short (prev mo.)5.39M
Technical
SMA 5022.47 (+12.4%)
SMA 20022.35 (+13.0%)
Beta0.92
S&P 52W Chg14.58%
Avg Vol (30d)477.93K
Avg Vol (10d)536.98K
Technical Indicators
RSI (14)60.6
MACD1.1633
MACD Signal1.1826
MACD Hist.-0.0193
BB Upper27.23 USD
BB Middle24.60 USD
BB Lower21.97 USD
BB Width21.39%
ATR (14)0.9338 USD
Vol Ratio (20d)0.68x